Background. Diabetic foot ulcers (DFUs) threaten limbs and prompt hospitalization. After hospitalization, remote-site invasive systemic infection related to DFU (DFU-ISI) may occur. The characteristics of DFU-ISIs and their effect on mortality risk have not been defined.
the index hospitalization and ulcer. For each index ulcer we reviewed hospital and outpatient clinic records for the subsequent 2 years. We excluded only those patients whose index DFU was not cultured or who underwent ipsilateral belowthe-knee amputation during the index hospitalization. The study was approved by the hospital's institutional review board.
Data Collection and Information on Variables
We collected patient data from the index hospitalization, including sex, age, comorbid medical conditions, prior diabetic foot medical and surgical history, Wagner classification of the DFU and severity of infection, ipsilateral ankle-brachial pressure index, and evidence of peripheral arterial disease, evidence of ipsilateral neuropathy, culture results from the index DFU (deep ulcer swab samples, adjacent abscess, debrided tissue or bone), surgical treatments including debridement and amputations limited to the foot, revascularization, antibiotic treatment, length of stay (LOS), and DFU wound status on hospital discharge. We collected data from the hospital and outpatient clinic records regarding subsequent treatment of the index ulcer, including culture results, readmission and LOS of each hospitalization, amputations, occurrence of DFU clinical infection or systemic infections, and survival.
We defined the severity of comorbid conditions using the modified Charlson comorbidity score [18, 19] , classified DFUs according to Wagner [20] , and judged the severity of foot infection using the features perfusion, extent, depth, infection and sensation (PEDIS) grading system [21] . We defined arterial insufficiency as either an ankle-brachial pressure index <0. 8 or evidence of limb hypoperfusion (nonpalpable peripheral pulse and cold limb) [13, 21, 22] . We accepted the diagnosis of osteomyelitis contiguous with the DFU if any of the following was present: (1) visible bone or positive probe-to-bone test; (2) compatible magnetic resonance imaging findings; (3) positive culture of bone obtained by surgical debridement or biopsy; or (4) histopathological evidence of osteomyelitis [23, 24] .
We defined wounds as surgically closed at discharge if, after debridement, ulcer excision, or a limited amputation, the sutured skin edges were well approximated or defects were covered by skin grafts. We considered a DFU healed when clinic records documented continuous viable skin covering the ulcer [25] . If an index ulcer healed without repeated hospitalization or surgery, we designated the healing course uncomplicated; if additional hospitalization or surgery was required, we defined the course as complicated. We calculated the duration of an open wound from the date of discharge from the index hospitalization to the date of documented complete healing.
Patient Classification and Outcome Measurement
Given the unique risk of invasive infection after S. aureus colonization, particularly that by methicillin-resistant S. aureus (MRSA), we assigned patients to groups according to the recovery of MRSA from the initial DFU and the healing course of the ulcer, as follows: group 1, wound culture negative for MRSA and uncomplicated healing; group 2, wound culture negative for MRSA and complicated healing; group 3, wound culture yielding MRSA and uncomplicated healing; and group 4, wound culture yielding MRSA and complicated healing.
ISIs involved a site other than the foot and occurred after the index hospitalization. They included bacteremia, focal endovascular infection, nonpedal osteomyelitis or septic arthritis, deep soft-tissue abscess (excluding skin and subcutaneous tissue), and pneumonia. We defined an ISI as DFU related (DFU-ISI) when the organism causing the ISI had been previously or was concomitantly cultured from the index DFU. We defined primary bacteremia, bacteremia from an infected DFU, and other infections considered the result of hematogenous seeding from the DFU (endovascular, skeletal, deep-tissue abscess) as stringent DFU-ISIs. We considered ISIs caused by organisms isolated from the DFU but probably arising by mechanisms other than hematogenous spread as nonstringent DFU-ISIs (eg, vascular catheter related bacteremia, pneumonia, urinary tract infection). We did not consider DFU contiguous osteomyelitis or septic arthritis without associated bacteremia to be DFU-ISI.
The primary study outcome was the occurrence of DFU-ISI within 24 months after the index hospitalization. The relationship of DFU-ISI to mortality rates at 2 years was a secondary outcome.
Statistical Analysis
We used variables easily obtained during index hospitalization and thereafter to investigate risk factors associated with DFUISIs. We considered each unique DFU an independent event, and these constituted the study number in our statistical analyses. We calculated means and SDs for continuous variables, and percentages for categorical variables. To compare clinical characteristics of patients with or without DFU-ISI we used χ 2 or Fisher exact tests for categorical values and Student t tests for continuous variables. We used the Kaplan-Meier method and log-rank tests to compare the 4 study groups with regard to the cumulative probability of the first DFU-ISI and survival after DFU-ISI. Bonferroni corrections of log-rank test P values were used to prevent potential multiple-comparison effects.
Using the classification and regression tree (CART) technique, we identified the optimal cutoff point based on the Gini index for the duration of an open DFU wound with regard to the risk of DFU-ISI. We screened for variables with P values ≤.10 by univariable analysis and included these as candidate variables in the multivariable Cox regression model. We then used backward selection (ie, removing variables with P values ≧.05) of these variables to investigate independent risk factors associated with DFU-ISI and 2-year mortality rates.
Patients with end-stage renal disease (ESRD) receiving hemodialysis have independent risks for bacteremia and hematogenous infection. Therefore, we excluded patients receiving hemodialysis, and as a post hoc sensitivity analyses we repeated the Cox regression analysis for predictors of initially defined and stringently defined DFU-ISIs.. Data were analyzed using SPSS software for Windows, version 16.0 (SPSS), and CART software (Salford Systems). All P values are 2 sided, and findings were considered statistically significant at P < .05.
RESULTS

Patient Population
We studied 846 diabetic patients who were hospitalized during the 9-year period for the treatment of 1256 unique index DFUs. We excluded from our analyses 27 patients with 44 DFUs who underwent below-the-knee amputation during the index hospitalization. The final study population includes 819 patients with 1212 unique index DFUs (Figure 1) . Figure 1 ).
Microbiology Results in DFU Cultures
Cultures from the index DFU (deep ulcer swab or tissue specimens) obtained within 72 hours of admission (Appendix Table A ) yielded multiple organisms in 70.5% of DFUs (854 of 1212), with a mean of 2.9 isolates per ulcer. S. aureus was recovered from 64.3% DFUs (779 of 1212); of these, 26% (321 of 1212) were MRSA. MRSA was isolated from an additional 130 index DFUs after discharge from the index hospitalization. Ultimately, MRSA was recovered from 37.2% of DFUs (451of 1212). Of the 1212 index DFUs, 141 (11.6%) were associated with ≥1 episode of DFU-ISI during 2 years of follow-up. Among these 141 index DFUs, 21 and 5 DFUs were associated with 2 or 3 separate DFU-ISI, respectively (Appendix Table B ). These additional episodes accounted for 31 DFU-ISIs, yielding a total of 172 DFU-ISIs. The mean (SD) duration of follow-up for the 141 and 1071 DFUs with or without DFU-ISI was 569 (224) and b Including angioplasty and bypass graft surgery for ipsilateral extremity.
c Only patients received surgical debridement were included for analysis.
d At the time of index hospitalization discharge.
e For the treatment of the index ulcer within 1 year after discharge from index hospitalization.
f Including LOS for index and subsequent hospitalization.
g Only patients with readmission history were included in this analysis.
h Including only ulcers that healed without amputation within 1 year of discharge from index hospitalization.
602 (226) days, respectively (P = .10). Figure 2 . Patients with MRSA isolated from an initial DFU culture and a complicated healing course (group 4) had the highest cumulative probability of DFU-ISI (31%); 41 of 51 DFU-ISIs (80%) in group 4 were caused by MRSA. Group 4 also had the lowest cumulative survival rate (87%). CART analysis revealed that the break points of open wound duration for the low and high risk of developing DFU-ISI were ≦145 days and >145 days (5.2% vs 21.4%), respectively. Table 3 shows the clinical characteristics and treatment of patients with or without subsequent DFU-ISI. Significantly higher percentages of patients with DFU-ISI had ESRD, cirrhosis, coronary artery disease, congestive heart failure (CHF),
Charlson comorbidity score ≧5, and a DFU culture yielding MRSA. Among patients with DFU-ISI, ulcers were more common in the midfoot or hindfoot and underwent complicated healing. Contiguous osteomyelitis, surgical debridement, and surgical wound closure at discharge were associated with a lower risk of DFU-ISI. Patients with DFU-ISIs required more frequent hospitalizations for treatment of the index DFU, longer average subsequent hospitalization, and more days hospitalized per 1000 follow-up days than noted in patients without DFU-ISI. Mortality rates were increased in those with DFU-ISIs. Of 17 patients who died after DFU-ISI, 10 did so within 30 days of diagnosis.
Multivariable Cox regression analysis showed that ESRD, CHF, initial wound culture yielding MRSA, and complicated ulcer healing were independently associated with increased risk for DFU-ISI. Successful surgical wound closure was associated with reduced risk for DFU-ISI (Table 4) . After excluding ESRD patients on hemodialysis, we performed 2 post hoc sensitivity analyses to further assess predictors of DFU-ISI (Appendix Table C ). One Cox regression analysis included all initial DFU-ISIs. The second model was restricted to stringent DFU-ISI (infections that probably resulted from bacteremia originating in the DFU). As in the original model, Including E. coli (n = 2), α-hemolytic streptococci (n = 2), Enterobacter cloacae (n = 2), Acinetobacter baumannii (n = 1), C. freundii (n = 1), and coagulase-negative staphylococci (n = 1). c Five episodes were polymicrobial infection: MRSA plus VRE (n = 1), MRSA plus α-hemolytic streptococci (n = 1), MSSA plus α-hemolytic streptococci (n = 1), MSSA plus group B streptococci (n = 1), and E. coli plus C. freundii (n = 1). Including vascular catheter-related infection (n = 10), primary bacteremia (n = 4), soft-tissue infection (n = 4), arteriovenous graft infection (n = 1), urinary tract infection (n = 1), and left external iliac artery pseudoaneurysm (n = 1). One episode was polymicrobial infection (K. pneumoniae plus P. aeruginosa). the independent predictors of increased risk for DFU-ISI in each analysis were CHF, initial wound culture yielding MRSA, and complicated ulcer healing. Cox regression analysis demonstrated that DFU-ISI was independently associated with increased mortality risk (hazard ratio, 1.987; 95% confidence interval [CI], 1.106-3.568; P = 0.02), as were age, high Charlson comorbidity score, and complicated ulcer healing (Table 4) .
DISCUSSION
Our study assessing the effect of DFU on later infections yielded 2 major findings. First, after initial hospitalization for treatment of DFUs, patients were at significant risk for developing DFU-ISIs. The risk was highest among patients with MRSA cultured from the initial DFU and complicated ulcer healing (ulcers open >145 days) Second, patients who experienced a DFU-ISI had a significantly higher mortality risk than those without an ISI.
Foot ulcers and their subsequent infection are common complications among diabetic patients and cause major morbid effects and a burden on the healthcare system [6, [26] [27] [28] . Medical groups experienced in the care of these patients report 1-year amputation and mortality rates ranging from 16% to 44% and 6% to 16%, respectively. These risks are highest risk when DFUs are complicated by infection or ischemia [10, 25, 29, 30] . Five years after treatment of an initial DFU, mortality rates range from 23% to 55%; however, it remains unclear whether these high rates relate to DFU or alternatively to comorbid conditions in these patients [29, 31, 32] . Our data indicate that during the 2 years after initial hospitalization for DFUs, DFU-ISIs significantly increase healthcare burdens, including significantly increased hospitalizations and LOS, and are associated with increased mortality rates. The temporal proximity of DFU-ISIs and death suggests that some ISIs may directly contribute to deaths.
The frequency and apparent pathogenicity of MRSA noted in our patient's DFU-ISIs are striking. MRSA was detected overall in 37% of 1212 DFUs but ultimately caused 57% of DFU-ISIs. MRSA carriage can be prolonged, is associated with breaks in the skin, and often is due to the persistence of a single unique strain [33, 34] . Furthermore, the presence of MRSA concurrently in cultures of the nares and DFUs is common, and heavier burdens of nasal MRSA are associated with an increased risk of invasive disease [35, 36] .
DFU-ISIs are independently associated with index DFU cultures yielding MRSA and ulcers with a complicated healing Figure 2 . Cumulative probability of the first diabetic foot ulcer-related invasive systemic infection (DFU-ISI) (A) and patient survival after discharge from index hospitalization (B). A, Significant group comparisons (log-rank test P < .008, with Bonferroni correction): group 4 versus groups 1, 2, and 3, group 3 versus group 1, and group 2 versus group 1. B, Significant group comparisons (log-rank test P < .008, with Bonferroni correction): group 4 versus groups 1, 2, and 3. Groups were defined as follows: group 1, without methicillin-resistant Staphylococcus aureus (MRSA)-positive wound culture at index hospitalization and with uncomplicated ulcer healing course; group 2: without MRSA-positive wound culture at index hospitalization and with complicated ulcer healing course; group 3, with MRSA-positive wound culture at index hospitalization admission and uncomplicated ulcer healing course; and group 4: with MRSA-positive wound culture on index hospitalization admission and complicated ulcer healing course.
course. This association persists when the analysis is restricted to patients who are not receiving hemodialysis and have stringently defined DFU-ISIs, those probably resulting from seeding during bacteremia. These findings support the plausibility of DFUs as a reservoir of organisms and a portal of entry for invasive infection. b Only patients who received surgical debridement were included for analysis.
c Including angioplasty and bypass graft surgery for ipsilateral extremity.
e Within 1 year after discharge from the index hospitalization.
f Only patients with readmission history were included in the analysis.
g Including LOS for index and subsequent hospitalization.
h Subsequent hospitalization days for index ulcer care. Including only ulcers that healed without amputation within 1 year of discharge from index hospitalization.
Other investigators have noted that MRSA colonization or infection, particularly in patients with chronic disease, is associated with subsequent MRSA invasive infection [37] [38] [39] [40] [41] . Roghmann et al [38] found a relative risk of 16 (95% CI, 6-45) for MRSA bacteremia among patients hospitalized with chronic ulcers (32% were diabetic ulcers) that were colonized with MRSA, compared with patients with noncolonized ulcers. In addition, Huang et al [39] , in a study of 591 hospitalized patients with newly detected MRSA in clinical cultures, found that 33% of these patients experienced 317 new unique site invasive MRSA infections during the ensuing year; 185 (58%) occurred after hospital discharge. Diabetes was an independent risk factor for MRSA infection. These infections, largely involving the lungs, skin and soft tissue, vascular catheters, skeletal structures, and blood stream, were associated with a 9.1% attributable mortality risk in this population with significant comorbid conditions, recent hospitalization, and wounds-a population not unlike our population with prolonged open DFU. Patients with MRSA carriage for >1 year are also at increased risks of invasive MRSA infection and death [41] .
Prevention of DFU through the application of demonstrably efficacious risk screening, education, and treatment strategies is the first step in preventing DFU-ISI [2] . Moreover, the association of prolonged open DFU wounds and MRSA in these wounds provides 2 potential targets for therapeutic intervention.
As has been suggested by others [10, 25, 38, 39] , strategies promoting more frequent and rapid healing of DFU and eradication of MRSA in patients such as ours might significantly decrease the frequency of DFU-ISI and the related adverse health consequences. The protective effect against ISI seen in our patients with osteomyelitis (which we think is a surrogate for aggressive debridement), surgical debridement, and surgical wound closure at discharge support this treatment approach.
Our study has limitations. First, it was a single-center study. Thus, generalization from our findings requires further confirmation, especially in settings with lower MRSA prevalence. Second, our clinical data were collected retrospectively and are therefore subject to information bias. Third, because not all study patients had completed a 2-year follow-up at our hospital, ISIs treated elsewhere would not have been detected. Fourth, because subsequent antibiotic treatment might reduce the risk of DFU-ISI, the unavailability of reliable data for antibiotic therapy after the initial treatment of index DFUs is a limitation. Although they do not invalidate our observations, the third and fourth limitations might result in our underestimating the true incidence of DFU-ISI. Finally, we cannot confirm for individual patients the relatedness of MRSA initially isolated from a DFU and those causing subsequent ISI. We think that these sequential MRSA isolates are probably related. Studies have shown that colonizing and subsequent infecting MRSA strains are often identical [33, 34] . In summary, our study demonstrates the increased morbid effects, burden of care, and mortality risk associated with DFUISIs, as well as the independent risk factors for DFU-ISIs. Our data are hypothesis generating. They suggest reduction in DFUISIs and associated mortality rates as end points for controlled trials examining MRSA eradication plus strategies to promote earlier DFU healing. Pending data from such trials, however, our observations suggest that clinicians should incorporate the risk of DFU-ISI into decision making when planning treatment for patients with DFUs. Strategies to eradicate MRSA when present and to facilitate rapid ulcer healing, such as aggressive surgical debridement, early attention to enhancement of arterial supply, and techniques to accelerate wound closure, should be considered.. These strategies may protect patients from later DFU-ISIs.
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